News 2012

December 2012:

Ensymm is demanded for a BP preparation and further consulting in order to establish a medical startup company in Germany.

 

Ensymm delivers a full set of 20 kW solar panel systems to MENA – turnkey „made in Germany“.

 

Ensymm delivers xylanase on regular basis from India to Germany for paper and feed industry.

 

November 2012:

Ensymm submits a blood bag plant BP to a KSA investor along with further support for the financing procedure, such as off-take agreement arrangements.

 

Ensymm submits a GAP analysis and a related comprehensive report for a biopolymer project to a GCC bio marine company. Based on ensymm marketing report findings, at site inspections and at site coordination, ensymm provides advice for a plant upgrade to reach a higher product standard.

 

Ensymm and Disolut start exploring the production of medical yeast capsules for EU for diarrhea diseases.

 

October 2012:

Ensymm arranges an off-take agreement contract successfully in order to support the client along with the preparation of a BP for bank application.

 

Ensymm delivers, on long term contract based, lactase bulk powder for drop production in Pakistan.

 

Ensymm delivers IV warmer to a regular client.

 

September 2012:

Ensymm prepares a project study for a mobile IV solution plant for Solomon Islands.

 

August 2012:

Ensymm prepares a project study to explore the industrial potential of seaweed and macro algae production.

 

July 2012:

Ensymm prepares a fully bankable BP for establishing a multi generic pharmaceutical factory in Africa.

 

June 2012:

Ensymm prepares an IV production BP for a member of the royal family Al-Thani in Qatar.

 

Ensymm prepares a bankable BP for a KSA investment group for IV solution and blood tube production as a package.

 

Ensymm transfers the process and technology for invert sugar processing to 3 Indian companies along with regular purchase of related invertase enzyme.

 

May 2012:

Ensymm prepares a BP for date syrup plant in MENA.

 

April 2012:

Ensymm delivers on regular base, drops and capsules for lactase intolerant consumers to a South African pharma-company.

 

March 2012:

Ensymm prepares a BP for an IV solution plant in KSA.

 

Ensymm prepares an Aloe Vera project study for an Iranian company and signs a consulting contract for establishing an Aloe Vera drink line along with European product license.

 

February 2012:

Ensymm prepares a Business Plan (BP) for an IV solution plant in Libya.

 

Ensymm delivers liquid lactase to Italy.

 

January 2012:

Ensymm signs a process transfer contract for lactase drop production and related enzyme supply in the UK.

 

Ensymm receives order for a chitosan production project study preparation in Africa.